Abstract
Carisoprodol and meprobamate are centrally acting muscle relaxant/anxiolytic drugs that can exist in a parent–metabolite relationship (carisoprodol → meprobamate) or as a separate pharmaceutical preparation (meprobamate aka Equanil, others). The monitoring of the use of these drugs has both clinical and forensic applications in pain management applications and in overdose situations. LC-MS/MS is used to analyze urine or plasma/serum extracts with deuterated analogs of each analyte as internal standards to ensure accurate quantitation and control for any potential matrix effects. Positive ion electrospray is used to introduce the analytes into the mass spectrometer. Selected reaction monitoring of two product ions for each analyte allows for the calculation of ion ratios which ensures correct identification of each analyte, while a matrix-matched calibration curve is used for quantitation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Tse SA, Atayee RS, Ma JD, Best BM (2014) Factors affecting carisoprodol metabolism in pain patients using urinary excretion data. J Anal Toxicol 38(3):122–128. doi:10.1093/jat/bku002
McMillin GA, Slawson MH, Marin SJ, Johnson-Davis KL (2013) Demystifying analytical approaches for urine drug testing to evaluate medication adherence in chronic pain management. J Pain Palliat Care Pharmacother 27(4):322–339. doi:10.3109/15360288.2013.847889
Backer RC, Zumwalt R, McFeeley P, Veasey S, Wohlenberg N (1990) Carisoprodol concentrations from different anatomical sites: three overdose cases. J Anal Toxicol 14(5):332–334
Gaillard Y, Billault F, Pepin G (1997) Meprobamate overdosage: a continuing problem. Sensitive GC-MS quantitation after solid phase extraction in 19 fatal cases. Forensic Sci Int 86(3):173–180
Daval S, Richard D, Souweine B, Eschalier A, Coudore F (2006) A one-step and sensitive GC-MS assay for meprobamate determination in emergency situations. J Anal Toxicol 30(5):302–305
Baselt RC (2011) Disposition of toxic drugs and chemicals in man, 9th edn. Biomedical Publications, Seal Beach, CA
Alvarez JC, Duverneuil C, Zouaoui K, Abe E, Charlier P, de la Grandmaison GL, Grassin-Delyle S (2012) Evaluation of the first immunoassay for the semi-quantitative measurement of meprobamate in human whole blood or plasma using biochip array technology. Clin Chim Acta 413(1–2):273–277. doi:10.1016/j.cca.2011.10.025
Coulter C, Garnier M, Tuyay J, Orbita J Jr, Moore C (2012) Determination of carisoprodol and meprobamate in oral fluid. J Anal Toxicol 36(3):217–220. doi:10.1093/jat/bks009
Essler S, Bruns K, Frontz M, McCutcheon JR (2012) A rapid quantitative method of carisoprodol and meprobamate by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 908:155–160. doi:10.1016/j.jchromb.2012.09.001
Sreenivasulu V, Ramesh M, Kumar IJ, Babu RV, Pilli NR, Krishnaiah A (2013) Simultaneous determination of carisoprodol and aspirin in human plasma using liquid chromatography-tandem mass spectrometry in polarity switch mode: application to a human pharmacokinetic study. Biomed Chromatogr 27(2):179–185. doi:10.1002/bmc.2766
Bevalot F, Gustin MP, Cartiser N, Gaillard Y, Le Meur C, Fanton L, Guitton J, Malicier D (2013) Using bone marrow matrix to analyze meprobamate for forensic toxicological purposes. Int J Leg Med 127(5):915–921. doi:10.1007/s00414-013-0833-8
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Slawson, M.H., Johnson-Davis, K.L. (2016). Quantitation of Carisoprodol and Meprobamate in Urine and Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). In: Garg, U. (eds) Clinical Applications of Mass Spectrometry in Drug Analysis. Methods in Molecular Biology, vol 1383. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3252-8_12
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3252-8_12
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3251-1
Online ISBN: 978-1-4939-3252-8
eBook Packages: Springer Protocols